FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Clonidine 300micrograms/24hours transdermal patches (Special Order) 1 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Osmanil 12micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Osmanil 12micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Generic GlucOsamine Gel Patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
GlucOsamine Gel Patch (William Ransom & Son Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Generic GlucOsamine Gel Patch 10 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
GlucOsamine Gel Patch (William Ransom & Son Plc) 10 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 100 patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Lexon (UK) Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Lexon (UK) Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 100 patches (Lexon (UK) Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 50 patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Minitran 10 transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 50 patches (Lexon (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Lexon (UK) Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Minitran 10 transdermal patches (Lexon (UK) Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Lexon (UK) Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Lexon (UK) Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Stephar (U.K.) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Stephar (U.K.) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 25 patches (Stephar (U.K.) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 100 patches (Stephar (U.K.) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Stephar (U.K.) Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Stephar (U.K.) Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 25 patches (Stephar (U.K.) Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 100 patches (Stephar (U.K.) Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 25 transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 50 transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 75 transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 100 transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 25 patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 100 patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 25 patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 50 patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 75 patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 25 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 50 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 75 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 100 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 25 patches (Mawdsley-Brooks & Company Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 100 patches (Mawdsley-Brooks & Company Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 25 patches (Mawdsley-Brooks & Company Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Mawdsley-Brooks & Company Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Mawdsley-Brooks & Company Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Mawdsley-Brooks & Company Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 50 patches (Mawdsley-Brooks & Company Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 75 patches (Mawdsley-Brooks & Company Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 3mg/24hours transdermal patches (UCB Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Waymade Healthcare Plc) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 3mg/24hours transdermal patches (UCB Pharma Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 1mg/24hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 1mg/24hours transdermal patches (UCB Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 1mg/24hours transdermal patches 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 1mg/24hours transdermal patches (UCB Pharma Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 5micrograms/hour transdermal patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Mawdsley-Brooks & Company Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Mawdsley-Brooks & Company Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (Mawdsley-Brooks & Company Ltd) 9 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Mawdsley-Brooks & Company Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Waymade Healthcare Plc) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Waymade Healthcare Plc) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 13 of 21 Next End

This concept is not in any reference sets

Back to Start